Panichi V, Bianchi A M, Andreini B, Casarosa L, Migliori M, De Pietro S, Taccola D, Giovannini L, Palla R
Department of Internal Medicine, University of Pisa, Italy.
Int J Artif Organs. 1998 Jul;21(7):408-13.
Postdilution hemofiltration with a polyamide membrane is a renal replacement technique widely used, but very little information is available regarding the biocompatibility of this treatment. In this paper we report the results of an acute study of the biocompatibility of polyamide hemofiltration.
Complement activation such as C3a and C5a Des Arg (RIA), granulocyte degranulation like alpha 1 elastase intradialytic increase (ELISA) and the expression of high affinity membrane receptors for IL-2 (anti-TAC) were determined. Beta 2-microglobulin (RIA) intradialytic decrease, as well as its convective removal, was evaluated. The nature of protein layer adsorbed onto the polyamide membrane, at the end of the dialytic session was investigated with a new immunohistochemical technique. Cell-associated cytokine concentration (like IL-1 beta and IL-1Ra - ELISA) was determined on mononuclear cell lysates.
A low degree of complement activation was detected with the polyamide membrane when data were adjusted for hemoconcentration and for 1 m2 of membrane surface area. An important convective removal not only of Beta 2-microglobulin (258+/-20 mg/session), but also of the activated anaphylatoxins (225+/-76 ng/ml for C3a and 22.5+/-4 ng/ml for C5a) was revealed. A marked deposition of all coagulation factors with no detectable amount of immunoglobulins and complement factors was revealed on the polyamide membrane at the end of the dialytic session. No intradialytic (for IL-1beta) (from 14. 1+/-3.0 to 13.5+/-2.9 pg/2.5 x 10(6) cell) and interdialytic (for IL-1Ra) (from 4572+/-1076 to 5408+/-615 pg/2.5 x 10(6) cell) cell-associated cytokine expression was induced by hemofiltration.
Polyamide hemofiltration is a highly biocompatible technique due to the use of a synthetic membrane with a sterile reinfusion fluid and the convective removal of the activated anaphylatoxins and Beta 2-microglobulin.
聚酰胺膜后稀释血液滤过是一种广泛应用的肾脏替代技术,但关于这种治疗的生物相容性的信息却非常少。在本文中,我们报告了聚酰胺血液滤过生物相容性的急性研究结果。
测定补体激活产物如C3a和C5a Des Arg(放射免疫分析法)、粒细胞脱颗粒情况如透析期间α1弹性蛋白酶的增加(酶联免疫吸附测定法)以及IL-2高亲和力膜受体的表达(抗TAC)。评估β2-微球蛋白(放射免疫分析法)透析期间的降低情况及其对流清除率。采用一种新的免疫组织化学技术研究透析结束时吸附在聚酰胺膜上的蛋白层的性质。测定单核细胞裂解物中细胞相关细胞因子浓度(如IL-1β和IL-1Ra - 酶联免疫吸附测定法)。
当对血液浓缩和1平方米膜表面积的数据进行调整后,发现聚酰胺膜引起的补体激活程度较低。不仅发现了β2-微球蛋白(258±20mg/次)的重要对流清除,还发现了活化过敏毒素的对流清除(C3a为225±76ng/ml,C5a为22.5±4ng/ml)。透析结束时,在聚酰胺膜上发现所有凝血因子有明显沉积,未检测到免疫球蛋白和补体因子。血液滤过未引起透析期间(IL-1β)(从14.1±3.0至13.5±2.9pg/2.5×10⁶细胞)和透析间期(IL-1Ra)(从4572±1076至5408±615pg/2.5×10⁶细胞)的细胞相关细胞因子表达。
聚酰胺血液滤过是一种高度生物相容的技术,这是由于使用了带有无菌回输液的合成膜以及对流清除活化过敏毒素和β2-微球蛋白。